Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Bioengineered hybrid scaffold makes muscle regeneration possible

SARS-CoV-2: CAN INCORPORATE THEIR GENOME IN THE HOST CELL

Dangerous Eye abnormalities linked to COVID-19, Revealed by MRI scans?

Bioengineered hybrid scaffold makes muscle regeneration possible
  • BiotechToday
  • World

Bioengineered hybrid scaffold makes muscle regeneration possible

bioxone February 26, 2021February 26, 2021

Sristi Raj Rai, Amity University Kolkata

The soft tissue that has the potential to produce a force that helps in voluntary/involuntary body movements is called muscle. The motion is a result of sliding movements of actin and myosin, the two protein filaments that help muscle contract. There are 3 types of muscles: skeletal (bone), cardiac (heart), and smooth (other organs). The muscular system is responsible for almost 40% of one’s body mass and it also can regenerate itself. The spontaneous muscle regeneration is contained to small scale, as in the case of volumetric muscle loss (VML), this power fails to work. 

The current solution consists of surgical procedures in which grafts or autologous muscle flaps are introduced. Following this, physical therapies are a must. Even then there is no certainty that the grafts are not going to get rejected by the body in the future. Apart from this, one of the therapeutic measures that can be taken involves transplanting cells (satellite cells/muscle stem cells, mesenchymal stem cells, or myoblasts). This might regenerate the damaged muscles. But there lies a problem of invasive muscle biopsies, cell availability, the short lifespan of cells, transplantation at the injured site, desired differentiation, controlling the 3D structure and the microenvironment. 

A group of researchers has successfully overcome the VML barrier by manufacturing a hybrid of natural (with high cell recognition and cell binding affinity) and synthetic (with better mechanical strength) scaffold. Thereafter, they engineered the same in a mouse model by direct cell reprogramming. The study has been recently reported in the journal – Advanced Materials. Reprogramming of fibroblasts into induced myogenic progenitor cells (iMPCs) was done, as they are cells of connective tissue that helps in the healing of the wound. The above conversion takes place only in presence of certain transcription factors. Parallelly, customized porous biocompatible polycaprolactone (PCL) fiber scaffolds were produced for muscle tissue engineering. The above artificial structure was filled with natural decellularized muscle extracellular matrix (MEM) hydrogel. Results showed fruitful muscle regeneration after the implantation and addition of the reprogrammed cells. Further studies are required in order to understand and know the minute details of this artificial system. 

Also read:SARS-CoV-2: CAN INCORPORATE THEIR GENOME IN THE HOST CELL

SOURCE – medicine, S., 2021. Study finds bioengineered hybrid muscle fiber for regenerative medicine. The New Indian Express. Available at: https://www.edexlive.com/news/2021/feb/22/study-finds-bioengineered-hybrid-muscle-fiber-for-regenerative-medicine-18415.html

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged bioengineering direct cell reprogramming fibroblasts hybrid scaffold muscle regeneration regenerative medicine stem cells tissue engineering volumetric muscle loss (VML)

One thought on “Bioengineered hybrid scaffold makes muscle regeneration possible”

  1. Pingback: Dangerous Eye abnormalities linked to COVID-19, Revealed by MRI scans? - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Dangerous Eye abnormalities linked to COVID-19, Revealed by MRI scans?

bioxone February 27, 2021

Anannya Roy, Amity University Kolkata The world has suffered from the impact of the COVID-19 pandemic since the beginning of 2020. Though scientists are working hard day and night to tackle the situation, it always seems like the virus has the upper hand. Recently, a shocking discovery was made that puzzled Researchers and Doctors from […]

MRI scans

Related Post

  • BiotechToday
  • World

Exosomes’ role in lung cancer metastasis

BioTech Today July 21, 2021July 20, 2021

Soumya Shraddhya Paul, Amity University, Noida Lung cancer is one of the leading causes of cancer-associated deaths in the world. According to WHO, around 1.8 million people all around the world succumbed to lung cancer. With the initial onset of tumor progression, metastasis is the cause of 70% of the mortalities. Due to this reason, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Native State Mass Spectrometry

bioxone June 22, 2021June 21, 2021

Shayan Ahmed, Jamia Millia Islamia, New Delhi Antibiotic resistance happens to be an important phenomenon emerging as a defence mechanism in bacteria. Antibiotic resistance mechanisms are the reason bacteria are able to counter the effects of antibiotics. Immeasurable and indiscriminate use of antibiotics ever since their discovery has contributed to the development of antibiotic resistance. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Long-term immunity against Coronavirus is a myth

bioxone October 5, 2020October 5, 2020

Devyani Goswami, Amity University Kolkata It is about a year now that the SARS-CoV-2 has disturbed and changed the daily lifestyle of people all over the world. A vaccine against this virus is what we are hoping for, but that too comes with a drawback that it won’t be able to provide a long-term immunity […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy